JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2006; 48:421-429, doi:10.1016/j.jacc.2006.04.068 (Published online 11 July 2006).
© 2006 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
j.jacc.2006.04.068v1
48/3/421    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (22)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mintz, G. S.
Right arrow Articles by Weissman, N. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mintz, G. S.
Right arrow Articles by Weissman, N. J.

STATE-OF-THE-ART PAPER

Intravascular Ultrasound in the Drug-Eluting Stent Era

Gary S. Mintz, MD*,a,* and Neil J. Weissman, MD{dagger},b

* Cardiovascular Research Foundation, New York, New York
{dagger} Washington Hospital Center, Washington, DC.

Manuscript received January 12, 2006; revised manuscript received March 15, 2006, accepted April 4, 2006.

* Reprint requests and correspondence: Dr. Gary S. Mintz, Cardiovascular Research Foundation, 611 Pennsylvania Avenue, SE #386, Washington, DC 20003. (Email: gsm18439{at}aol.com).

Intravascular ultrasound (IVUS) has become an indispensable part of all drug-eluting stent (DES) studies; findings must be put into context with the IVUS findings in bare metal stents. Unfortunately, there is not yet a complete picture of either the Cypher (Cordis, Miami, Florida) or the Taxus (Boston Scientific, Maple Grove, Minnesota) stent (the two U.S. Food and Drug Administration-approved devices). Intimal hyperplasia volume in DES is reduced to <15% of stent volume, but stent underexpansion continues to be a consistent finding in DES failures (restenosis and thrombosis). The utility of IVUS to assure adequate stent expansion may be more important whenever there are clinical risk factors for DES failure.

Abbreviations and Acronyms
  BMS = bare-metal stent
  CSA = cross-sectional area
  EEM = external elastic membrane
  IH = intimal hyperplasia
  ISR = in-stent restenosis
  IVUS = intravascular ultrasound
  LAD = left anterior descending
  LMCA = left main coronary artery
  LSM = late stent malapposition
  MSA = minimum stent CSA
  P&M = plaque and media




This article has been cited by other articles:


Home page
J Am Coll Cardiol IntvHome page
J. Aoki, G. S. Mintz, N. J. Weissman, J. T. Mann, L. Cannon, J. Greenberg, E. Grube, A.R. Z. Masud, J. Koglin, L. Mandinov, et al.
Chronic Arterial Responses to Overlapping Paclitaxel-Eluting Stents: Insights From Serial Intravascular Ultrasound Analyses in the TAXUS-V and -VI Trials
J. Am. Coll. Cardiol. Intv., April 1, 2008; 1(2): 161 - 167.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
E. De Benedetti and P. Urban
Coronary stenting: why size matters
Heart, December 1, 2007; 93(12): 1500 - 1501.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Windecker and B. Meier
Late Coronary Stent Thrombosis
Circulation, October 23, 2007; 116(17): 1952 - 1965.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. Jaffe and B. H. Strauss
Late and Very Late Thrombosis of Drug-Eluting Stents: Evolving Concepts and Perspectives
J. Am. Coll. Cardiol., July 10, 2007; 50(2): 119 - 127.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. R. Holmes Jr, D. J. Kereiakes, W. K. Laskey, A. Colombo, S. G. Ellis, T. D. Henry, J. J. Popma, P. W.J.C. Serruys, T. Kimura, D. O. Williams, et al.
Thrombosis and Drug-Eluting Stents: An Objective Appraisal
J. Am. Coll. Cardiol., July 10, 2007; 50(2): 109 - 118.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. V. Finn, G. Nakazawa, M. Joner, F. D. Kolodgie, E. K. Mont, H. K. Gold, and R. Virmani
Vascular Responses to Drug Eluting Stents: Importance of Delayed Healing
Arterioscler. Thromb. Vasc. Biol., July 1, 2007; 27(7): 1500 - 1510.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Cook, P. Wenaweser, M. Togni, M. Billinger, C. Morger, C. Seiler, R. Vogel, O. Hess, B. Meier, and S. Windecker
Incomplete Stent Apposition and Very Late Stent Thrombosis After Drug-Eluting Stent Implantation
Circulation, May 8, 2007; 115(18): 2426 - 2434.
[Abstract] [Full Text] [PDF]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2006 by the American College of Cardiology Foundation.